6472 — Bora Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD66.81bn
- TWD82.28bn
- TWD19.25bn
- 47
- 34
- 38
- 30
Annual cashflow statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 595 | 1,024 | 1,840 | 4,064 | 4,955 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -337 | 70.6 | 197 | 1,269 | -1,172 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -221 | -68.1 | -352 | -1,325 | -3,828 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 178 | 1,237 | 2,010 | 4,614 | 981 |
| Capital Expenditures | -152 | -364 | -193 | -1,389 | -687 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,386 | 138 | -4,088 | -1,069 | -9,993 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,538 | -226 | -4,281 | -2,458 | -10,680 |
| Financing Cash Flow Items | -19 | -54.3 | 472 | -85.7 | -337 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,578 | -741 | 4,595 | -2,440 | 12,071 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 217 | 241 | 2,371 | -228 | 2,776 |